Key Facts

Lilly at a Glance

  • Founded May 10, 1876

  • Headquartered in Indianapolis, USA

  • Lilly introduced the world's first commercial insulin in 1923

  • More than 42,000 employees worldwide

  • Approximately 10,000 employees engaged in research and development

  • Products marketed in 110 countries

Research & Development

  • £535 million invested in UK R&D between 2019 and the end of 2023

  • Percentage of total workforce engaged in R&D: 23.9%

  • Research and development facilities located in 7 countries

  • Clinical research conducted in more than 55 countries

  • Manufacturing sites located in 7 countries

Our Employees

  • Of our more than 42,000 employees worldwide, around 19,800 are in the US and 23,100 are outside the US (2023)

  • Nearly 570 people employed in the UK (2023)

  • Percentage of women in management in the UK: 47% (2023)

  • Racial and ethnic minority representation in management in the US: 25% (2022)

Social Impact

  • In 2022, Lilly employees, retirees and the Lilly Foundation contributed more than $12 million to United Way

  • Since 2009, Lilly has donated more than 5.2 million vials and cartridges of insulin through  Life for a Child

  • Almost 200,000 people screened for breast and cervical cancer in Kenya through AMPATH partnership

  • More than 1 million employee volunteer hours through Lilly Global Day of Service since 2008

Cost of Pharmaceuticals

  • Average cost to discover and develop a new drug: $2.6 billion

  • Average length of time from discovery to patient: 10 years